You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 10,576,165


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,576,165 protect, and when does it expire?

Patent 10,576,165 protects TPOXX and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 10,576,165
Patent landscape, scope, and claims:
Title:ST-246 liquid formulations and methods
Abstract: The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.
Inventor(s): Tyavanagimatt; Shanthakumar R. (Corvallis, OR), Anderson; Melialani A. C. L. S. (Corvallis, OR), Weimers; William (Corvallis, OR), Kasi; Gopi Krishna (Lynnwood, WA), Samuel; N K Peter (Corvallis, OR), Bolken; Tove C. (Keizer, OR), Hruby; Dennis E. (Albany, OR)
Assignee: Siga Technologies Inc. (Corvallis, OR)
Application Number:16/157,343
Patent Claim Types:
see list of patent claims
Formulation; Compound;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,576,165

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Siga Technologies TPOXX tecovirimat SOLUTION;INTRAVENOUS 214518-001 May 18, 2022 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,576,165

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 082566 ⤷  Subscribe
Argentina 122178 ⤷  Subscribe
Australia 2011285871 ⤷  Subscribe
Brazil 112013002646 ⤷  Subscribe
Canada 2807528 ⤷  Subscribe
China 103281898 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.